Yao MA

Title: Yao Ma: Innovator in Pharmaceutical Technology

Introduction

Yao Ma is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of compounds that have potential applications in cancer treatment. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Yao Ma holds a patent for a deuterated 1,4-benzodiazepine-2,5-dione compound and its use. This patent discloses a compound represented by a specific formula or a pharmaceutically acceptable salt thereof. The active compound is noted for its ability to inhibit tumor cells and tumor stem cells effectively. Additionally, it prolongs the degradation function of in-vitro human liver microsomes on the compound, significantly extending its half-life period. This advancement provides a safer and more reliable candidate for developing new anti-tumor drugs.

Career Highlights

Yao Ma is associated with Ningbo Combireg Pharmaceutical Technology Co., Ltd., where he applies his knowledge and skills in pharmaceutical research and development. His work at this company has been instrumental in pushing the boundaries of what is possible in cancer treatment.

Collaborations

Yao Ma has collaborated with notable colleagues, including Gang Liu and Wenjun Yu. These partnerships have fostered an environment of innovation and have contributed to the success of their projects.

Conclusion

Yao Ma's contributions to pharmaceutical technology, particularly through his patent on a deuterated compound, highlight his role as an innovator in the field. His work not only advances scientific knowledge but also holds promise for future medical applications.